Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GlobeNewswire
Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®
July 27, 2020 -
PR Newswire
Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
July 24, 2020 -
Genetic Engineering & Biotechnology News
Orchard Therapeutics Inks Deal for GSK’s Stable Cell Line Technology
July 23, 2020 -
GlobeNewswire
Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma
July 23, 2020 -
Business Wire
Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors
July 23, 2020 -
GlobeNewswire
Ultragenyx Announces U.S. Commercial Launch of Dojolvi™ (triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
July 22, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for OTL-203 for the Treatment of MPS-I
July 21, 2020 -
Business Wire
SonderMind Announces Therapist Network Expansion in Ohio
July 20, 2020 -
FierceBiotech
COVID-19 close-up: Nocion CEO Batycky on controlling cough to control spread
July 16, 2020 -
PR Newswire
Centene and Quartet Health expand partnership nationwide to help ensure members have access to critical behavioral health care during COVID-19 pandemic and beyond
July 16, 2020 -
FierceBiotech
New Insilico Medicine spinout to tackle longevity, COVID-19
July 15, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
July 15, 2020 -
GlobeNewswire
Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV
July 15, 2020 -
Deal Street Asia
China’s Citrine Medicine closes $80m in Series A Round
July 14, 2020 -
The Motley Fool
Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion
July 14, 2020 -
PR Newswire
Protenus Selected as One of the Best Places to Work in Healthcare for Third Consecutive Year
July 14, 2020 -
GlobeNewswire
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
July 9, 2020 -
Xconomy
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep
July 9, 2020 -
Kyruus
SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
July 8, 2020 -
Reuters
Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals
July 7, 2020 -
GlobeNewswire
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
July 6, 2020 -
GlobeNewswire
Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation
July 2, 2020 -
Crunchbase
French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More Collaborative
July 1, 2020 -
PR Newswire
Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers
July 1, 2020 -
Business Wire
Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform
July 1, 2020 -
ACN Newswire
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin
July 1, 2020 -
GlobeNewswire
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
June 30, 2020 -
Business Wire
Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting
June 27, 2020 -
PR Newswire
PatientPing Launches Route Solution to Guarantee Hospital E-Notifications Condition of Participation Compliance Under CMS’s Interoperability and Patient Access Rule
June 24, 2020 -
Business Wire
Compass Therapeutics Completes Reverse Merger and Closes $60 Million Private Placement
June 24, 2020 -
PR Newswire
TraceLink Announces Results from FDA DSCSA Pilot Program
June 23, 2020 -
PR Newswire
Sana Biotechnology Announces Completion Of Initial Financing
June 23, 2020 -
GlobeNewswire
Tempest Therapeutics Announces First Patient Dosed With the Combination of TPST-1120 Plus Nivolumab in a Phase 1 Study in Patients With Advanced Solid Tumors
June 22, 2020 -
PR Newswire
Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
June 19, 2020 -
Business Wire
Jackie Schumacher Joins Rallybio to Lead Global Regulatory Affairs
June 19, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China
June 18, 2020 -
GlobeNewswire
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial
June 18, 2020 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
June 18, 2020 -
Business Wire
Xilio Therapeutics Appoints Daniel S. Lynch as Chair of Board of Directors
June 17, 2020 -
PR Newswire
Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 16, 2020 -
GlobeNewswire
Hua Medicine’s Dorzagliatin Demonstrates Improvements in β-Cell Function in Data Presented at the American Diabetes Association’s 80th Scientific Sessions
June 15, 2020 -
Business Wire
Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
June 15, 2020 -
ExpressPharma
Caplin Steriles gets USFDA approval for Phenylephrine Hydrochloride Injection USP
June 12, 2020 -
Reuters
Apellis Pharmaceuticals Says Phase 3 Pegasus Study For Pegcetacoplan Met Primary Endpoint For Efficacy
June 12, 2020 -
FierceBiotech
Biotech Verve banks $63M to move gene-editing heart attack treatment toward clinic
June 11, 2020 -
Xconomy
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes
June 11, 2020 -
PR Newswire
Avidity Biosciences Announces Pricing of Initial Public Offering
June 11, 2020 -
PR Newswire
Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories
June 10, 2020 -
Business Wire
Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
June 10, 2020 -
PR Newswire
PatientPing Secures $60 Million in Series C Funding to Continue Expansion of National Electronic Notifications Network
June 9, 2020 -
GlobeNewswire
Denali Therapeutics Provides Broad Update on Its RIPK1 Program Partnered With Sanofi
June 9, 2020 -
PR Newswire
NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis
June 9, 2020 -
PR Newswire
Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies
June 9, 2020 -
PR Newswire
Buoy Health Launches Back with CareTM and Forms Advisory Board to Support Safe Return to the Workplace
June 8, 2020 -
Nasdaq
Muscle disorder biotech Avidity Biosciences sets terms for $150 million IPO
June 8, 2020 -
GlobeNewswire
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
June 8, 2020 -
GlobeNewswire
Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
June 8, 2020 -
Business Wire
NodThera Announces Close of $55 Million Series B Financing
June 3, 2020 -
PR Newswire
Innovent Announces the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study
June 1, 2020 -
PR Newswire
TraceLink Achieves ISO 9001:2015 Certification for Quality Management
June 1, 2020 -
GlobeNewswire
Hua Medicine Selected for Inclusion in the MSCI Hong Kong Micro Cap Index
May 31, 2020 -
PR Newswire
TraceLink Introduces New Agile Issue Management Solution
May 28, 2020 -
PR Newswire
Firefly Health Launches Return To Work Service To Support The Reopening Plans Of Massachusetts Businesses
May 28, 2020 -
GlobeNewswire
Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
May 27, 2020 -
GlobeNewswire
Arvelle Announces Closing of Final Tranche of Series A Financing Round
May 26, 2020 -
PR Newswire
KCNT1 Epilepsy Foundation, LunaPBC, and Genetic Alliance to Launch Patient-Led Discovery Program
May 26, 2020 -
FierceBiotech
Biotech Muscle disorder biotech Avidity aims for the clinic with $100M IPO
May 26, 2020 -
GlobeNewswire
Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
May 21, 2020 -
FierceBiotech
Rallybio scores $145M, unveils lead rare disease program
May 19, 2020 -
PR Newswire
Innovent Biologics and MD Anderson Announce a Strategic Collaboration to Develop anti-PD-1 Therapy TYVYT® (Sintilimab Injection) in Rare Cancers
May 18, 2020 -
GlobeNewswire
Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I
May 15, 2020 -
GlobeNewswire
Ultragenyx Announces Positive Data from Confirmatory Cohort of Phase 1/2 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
May 15, 2020 -
HIT Consultant
Boston Children’s Hospital Taps Kyruus to Power Digital Access Initiatives
May 14, 2020 -
PR Newswire
TraceLink Hosts Webinar to Help Pharma Prepare for Supply Chain Disruptions in the “Next Normal”
May 14, 2020 -
MedCityNews
With new lung cancer data at ASCO, Blueprint Medicines nips at Eli Lilly’s heels
May 14, 2020 -
GlobeNewswire
Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
May 13, 2020 -
PR Newswire
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020 -
GlobeNewswire
SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets – Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting
May 12, 2020 -
GlobeNewswire
Arvelle Therapeutics: SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy
May 12, 2020 -
FierceBiotech
Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead
May 12, 2020 -
GlobeNewswire
Tempest Therapeutics Announces First Patient Dosed in TPST-1495 Clinical Study: Dual EP2/4 Antagonist Targeting Solid Tumors
May 7, 2020 -
PR Newswire
FARAPULSE’s Pioneering Clinical Results Link Compelling Long-term Outcomes to Established Safety and Lesion Durability Data
May 7, 2020 -
TechCrunch
Owkin raises $25 million as it builds a secure network for healthcare analysis and research
May 7, 2020 -
PR Newswire
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
May 7, 2020 -
PR Newswire
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
May 6, 2020 -
GlobeNewswire
GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
May 4, 2020 -
Business Wire
SonderMind hires Douglas Newton, MD, MPH as Chief Medical Officer
May 4, 2020 -
EurekAlert
Frost & Sullivan recognizes Insilico as innovation leader in drug discovery
April 30, 2020 -
PR Newswire
Pharmaceutical Manufacturers and Wholesalers Continue to Choose TraceLink As Industry Readies for DSCSA Saleable Returns Verification Requirement
April 29, 2020 -
GlobeNewswire
Apellis Reports Analysis from Phase 1b Geographic Atrophy Study
April 28, 2020
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.